Ring Closure To Form Metal Chelates in 3D Fragment-Based de Novo Design

被引:18
|
作者
Foscato, Marco [1 ]
Houghton, Benjamin J. [2 ]
Occhipinti, Giovanni [1 ]
Deeth, Robert J. [2 ]
Jensen, Vidar R. [1 ]
机构
[1] Univ Bergen, Dept Chem, N-5007 Bergen, Norway
[2] Univ Warwick, Dept Chem, Inorgan Computat Chem Grp, Coventry CV4 7AL, W Midlands, England
基金
英国工程与自然科学研究理事会;
关键词
SPIN-STATE ENERGETICS; COMPUTER-AIDED-DESIGN; IN-SILICO DESIGN; GENETIC ALGORITHM; MANGANESE(II) COMPLEXES; AUTOMATED GENERATION; MOLECULAR-MECHANICS; CROSSOVER; LIGANDS; IRON(II);
D O I
10.1021/acs.jcim.5b00424
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
We describe a method for the design of multicyclic compounds from three-dimensional (3D) molecular fragments. The 3D building blocks are assembled in a controlled fashion, and closable chains of such fragments are identified. Next, the ring-closing conformations of such formally closable chains are identified, and the 3D model of a cyclic or multicyclic molecule is built. Embedding this method in an evolutionary algorithm results in a de novo design tool capable of altering the number and nature of cycles in species such as transition metal compounds with multidentate ligands in terms of, for example, ligand denticity, type and length of bridges, identity of bridgehead terms, and substitution pattern. An application of the method to the design of multidentate nitrogen-based ligands for Fe(II) spin-crossover (SCO) compounds is presented. The best candidates display multidentate skeletons new to the field of Fe(II) SCO yet resembling ligands deployed in other fields of chemistry, demonstrating the capability of the approach to explore structural variation and to suggest unexpected and realistic molecules, including structures with cycles not found in the building blocks.
引用
收藏
页码:1844 / 1856
页数:13
相关论文
共 50 条
  • [31] e-Drug3D: 3D structure collections dedicated to drug repurposing and fragment-based drug design
    Pihan, Emilie
    Colliandre, Lionel
    Guichou, Jean-Francois
    Douguet, Dominique
    BIOINFORMATICS, 2012, 28 (11) : 1540 - 1541
  • [32] LigandDiff: de Novo Ligand Design for 3D Transition Metal Complexes with Diffusion Models
    Jin, Hongni
    Merz Jr, Kenneth M.
    JOURNAL OF CHEMICAL THEORY AND COMPUTATION, 2024, 20 (10) : 4377 - 4384
  • [33] FragGen: towards 3D geometry reliable fragment-based molecular generation
    Zhang, Odin
    Huang, Yufei
    Cheng, Shichen
    Yu, Mengyao
    Zhang, Xujun
    Lin, Haitao
    Zeng, Yundian
    Wang, Mingyang
    Wu, Zhenxing
    Zhao, Huifeng
    Zhang, Zaixi
    Hua, Chenqing
    Kang, Yu
    Cui, Sunliang
    Pan, Peichen
    Hsieh, Chang-Yu
    Hou, Tingjun
    CHEMICAL SCIENCE, 2024, 15 (46) : 19452 - 19465
  • [34] De novo design with deep generative models based on 3D similarity scoring
    Papadopoulos, Kostas
    Giblin, Kathryn A.
    Janet, Jon Paul
    Patronov, Atanas
    Engkvist, Ola
    BIOORGANIC & MEDICINAL CHEMISTRY, 2021, 44
  • [35] 3D-RISM-Docc: A New Fragment-Based Drug Design Protocol
    Nikolic, Dragan
    Blinov, Nikolay
    Wishart, David
    Kovalenko, Andriy
    JOURNAL OF CHEMICAL THEORY AND COMPUTATION, 2012, 8 (09) : 3356 - 3372
  • [36] COMP 315-Fragment based de novo design
    Bohacek, Regine S.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2008, 236
  • [37] Synthesis and Chemoinformatic Analysis of Fluorinated Piperidines as 3D Fragments for Fragment-Based Drug Discovery
    Le Roch, Myriam
    Renault, Jacques
    Argouarch, Gilles
    Lenci, Elena
    Trabocchi, Andrea
    Roisnel, Thierry
    Gouault, Nicolas
    Lalli, Claudia
    JOURNAL OF ORGANIC CHEMISTRY, 2024, 89 (07): : 4932 - 4946
  • [38] Fragment-based drug design as a means of identifying novel dopamine D3 antagonists
    Pellegrene, Kendy
    Surratt, Christopher
    Madura, Jeffry
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2016, 251
  • [39] Escape from planarity in fragment-based drug discovery: A synthetic strategy analysis of synthetic 3D fragment libraries
    Klein, Hanna F.
    Hamilton, David J.
    de Esch, Iwan J. P.
    Wijtmans, Maikel
    O'Brien, Peter
    DRUG DISCOVERY TODAY, 2022, 27 (09) : 2484 - 2496
  • [40] MOLMAKER: De novo generation of 3D databases for use in drug design
    Clark, DE
    Firth, MA
    Murray, CW
    JOURNAL OF CHEMICAL INFORMATION AND COMPUTER SCIENCES, 1996, 36 (01): : 137 - 145